Cre重组酶表达与纯合FLT3内部串联重复敲入小鼠模型协同诱导急性髓系白血病
本文报道一种FLT3-ITD诱导疾病的转基因小鼠模型,其中仅Cre重组酶表达、无条件等位基因时即可产生侵袭性白血病表型。多种Cre重组酶表达导致FLT3ITD/ITD祖细胞多克隆扩增、分化阻滞及Myc依赖性基因表达程序激活,作者旨在提醒使用该特定小鼠模型研究协同致癌突变时注意Cre表达的意外效应。
要点
- 仅Cre重组酶表达、无条件等位基因时即可诱导侵袭性白血病表型。
- 多种Cre重组酶表达导致FLT3ITD/ITD祖细胞多克隆扩增和分化阻滞。
- Cre表达激活Myc依赖性基因表达程序,需警惕该模型用于协同突变研究的风险。
核心结论
- 仅Cre重组酶表达即可与纯合FLT3-ITD敲入小鼠模型协同诱导侵袭性白血病表型,作者提醒使用该特定小鼠模型研究协同致癌突变时注意Cre表达的意外效应。
研究设计与样本
- 转基因小鼠模型研究,报道FLT3-ITD诱导疾病的模型中Cre重组酶表达的影响。
主要发现
- 仅Cre重组酶表达、无条件下等位基因时即产生侵袭性白血病表型。
- 多种Cre重组酶表达导致FLT3ITD/ITD祖细胞多克隆扩增。
- Cre重组酶表达诱导分化阻滞并激活Myc依赖性基因表达程序。
临床怎么用
- 作者提醒科学界注意使用该特定小鼠模型及研究小鼠癌症模型协同致癌突变时Cre表达相关的潜在风险与意外效应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Murine models offer a valuable tool to recapitulate genetically defined subtypes of AML, and to assess the potential of compound mutations and clonal evolution during disease progression. This is of particular importance for difficult to treat leukemias such as FLT3 internal tandem duplication (ITD) positive AML. While conditional gene targeting by Cre recombinase is a powerful technology that has revolutionized biomedical research, consequences of Cre expression such as lack of fidelity, toxicity or off-target effects need to be taken into consideration. We report on a transgenic murine model of FLT3-ITD induced disease, where Cre recombinase expression alone, and in the absence of a conditional allele, gives rise to an aggressive leukemia phenotype. Here, expression of various Cre recombinases leads to polyclonal expansion of FLT3ITD/ITD progenitor cells, induction of a differentiation block and activation of Myc-dependent gene expression programs. Our report is intended to alert the scientific community of potential risks associated with using this specific mouse model and of unexpected effects of Cre expression when investigating cooperative oncogenic mutations in murine models of cancer.
引用
- Straube J, Eifert T, Vu T, et al. Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia. Leukemia. 2023. PMID: 36739348. doi:10.1038/s41375-023-01832-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。